//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon


Online Registration is Open!
Register by Friday, December 11 to Save $600 off standard rates.
»Pricing Chart

Add to Outlook Calendar

Find Another IBC Event

TIDES: Oligonucleotide and Peptide Therapeutics


May 09-12, 2016
Long Beach Convention & Entertainment Center
Long Beach, CA

Event Overview

Event Overview

The industry's #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate products from early discovery through late-stage development and commercialization

IBC's 18th Annual TIDES 2016 conference and exhibition is the #1 industry forum for CMC, clinical and discovery scientists to share strategies to accelerate oligonucleotide and peptide product development. TIDES 2016 is the only event in the field to provide complete coverage of the oligonucleotide and peptide market from discovery to manufacturing. By attending, you will learn from multiple case studies designed to facilitate scientific exchange and networking to improve your oligo and peptide drug development and manufacturing operations. Returning to California with an expanded program in 2016 we hope you can join the IBC Team and over 800 expected attendees from around the world!

Give Your Input on Topics/Speakers for the 2016 Program
Contact the TIDES Conference Producer Today: Michael Keenan at Mkeenan@ibcusa.com or Tel: 949-276-2634.

Keynote and Featured Speakers Provide Novel Strategies to Accelerate Product Approval

Richard DiMarchi

Mixed-Incretin Receptor Biochemical Signaling at Multiple Receptors Richard DiMarchi (Speaker Bio)
Standiford H. Cox Professor of Chemistry and Linda & Jack Gill Chair in Biomolecular Sciences
Indiana University

Robert Baffi, Ph.D.

Drisapersen: Case Study Robert Baffi, Ph.D.
Executive VP, Technical Operations
BioMarin Pharmaceutical

Danny Zurr, Ph.D.

Quark's Long History of Oligonucleotide Development Danny Zurr, Ph.D.
Chairman and Chief Executive Officer
Quark Pharmaceuticals Inc.

"The premier event to obtain an overview on hot topics in oligos and peptides and to network with opinion leaders" - Alex Fässler, Bachem AG, Switzerland

What's New for TIDES 2016

  • Expanded emphasis on oligo and peptide delivery and permeability
  • More late stage development and CMC topics
  • Business, M&A, funding and market landscape trends in oligos and peptides
  • More content on oligo-peptide conjugates and bioconjugation
  • Advances in peptide vaccines
  • Advances in mRNA therapeutics
  • Expanded emphasis on process validation, regulatory and specifications
  • Applications of CRISPR and genome editing in oligos and peptides
  • More drug product/fill-finish/aseptic processing topics
  • More clinical updates and lessons learned
  • More interactive panel discussions and discussion forums
  • "Hot topic" small group roundtables/breakfast discussions moderated by speakers
  • Dedicated poster viewing times and oral poster sessions

"TIDES always manages to be interesting for industry and academia alike" - Roland Brock, Radboud University Medical Centre

Get Your Approval to Attend Today so You Can Participate in the Following Ways

  • Present a poster and share your own research
  • Evaluate technologies and services from over 70 exhibitors
  • Network with over 800 fellow attendees using the new partnering tool
  • Meet over 100 renowned speaker experts in oligo and peptide discovery, preclinical, clinical and chemistry, manufacturing and controls

Register Now

"We started attending TIDES five years ago on the recommendation of an oligo therapeutics client. We find that this venue offers unique access to 'C' level scientists from around the globe and the lectures are… first-rate" - Tom Falzareno, Tandem Labs

Check back to the website as we confirm details for TIDES 2016. Subscribe here to receive email alerts and registration discounts for next year's meeting:

Email Opt-In